Medawar was devoted to family life. From when they first met as undergraduates in Oxford, his wife Jean (nee Taylor) and Peter were always together: I remember them surrounded by their four dynamic and much loved children; at endless dinner parties, and evening parties which seemed sometimes to contain all the coming biologists in Britain; when the children were young, surrounded by charming au ; at the opera, Peter's second great love after science; on grand occasions, perhaps on the way to the Palace; cycling together round the Bahamas; usually with friends, of whom they had a vast circle, for both were intensely social, and all Peter's research students became their friends. The large houses that they inhabited, in Edgbaston and then in London at Hampstead Square and Mount Vernon will be remembered with great affection.
Peter was devoted to his mother and to his sister Pamela, but that did not diminish his pleasure in occasionally crushing them at a hand of Bridge. H e loved cricket, especially when playing on the same side as his son Charles. In 1969 Peter suffered a severe stroke while delivering his magnificent address to the British Association and was for the rest of his life utterly dependent on Jean's unstinting support.
Those of us who were taught by him in Oxford remember him as a witty, dramatic, and enthusiastic lecturer: the coming man, but still in the wake of two other great teachers, E.B. Ford and J.R. Baker. The best lecture I have ever heard was given by him to the Oxford Science Society, on 'The Scientific M ethod', all about axioms, verification and metatheory, his special blend of the lucid, the creative, and the inspiring. To be tutored by him was to be taken apart and put together again with panache, but always with encouragement.
He was brought up in Oxford by E.S. Goodrich and by his tutor J.Z. Young in the great tradition of comparative anatomy, something which gave a unified core to zoology but still left time for vigorous excursions into the neighbouring disciplines. Although the War changed the direction of his life, he retained an affectionate and original interest in that tradition: in morphogenesis (11)*, in why lives on its side (22) , and in how embryonic induction made possible the evolution of tunicates (28) . Later at University College London (UCL) he did what he could to maintain that core. He took an enthusiastic interest in the newly developing branch of zoology that came to be termed 'ethology' and was instrumental in bringing Nikko Tinbergen to Oxford.
As a young scientist he was much influenced by H.W. (later Lord) Florey and by Sir Robert Robinson, as well as by the philosophers A.J. Ayer, T.D. Weldon and K.R. Popper.
His great joy was to create scientific ideas, to test them by experiment and then to communicate them in turn to his colleagues, to the scientific community, and to the world. His second greatest pleasure in science was to understand someone else's idea. He had no time for pages of data and set no great store by long-term planning, or by the organization of a large team. H e laughed at the pompous, and especially at those who complained of being crushed by the burden of administration. At the National Institute he survived by reserving Tuesdays and Thursdays exclusively for his own laboratory work, and continued to do his own washing up. But let no one imagine that this lessened his impact, either on the National Institute or on the three departments that he headed. His colleagues well understood the calibre of their leader and judge.
From Magdalen College he learned intellectual self-confidence: his autobiography tells us that he liked to feel able to master any subject. His interest in scientific method and his intercourse with philosophers led him to write for a wide public. Within his eleven books I recommend starting with Is the scientific paper a fraud? and the blistering review of Teilhard de Chardin, for entertainment value as well as for their insight. All that took time and he seemed never to waste a moment, a thought, or a finding. One day his friend James Gowans caught him at the typewriter with a cigarette hanging from his mouth, and was told 'it takes an effort to write undying prose'.
During his last (nearly) two decades at the Clinical Research Centre he was physically incapacitated, though ideas continued to flow; he found a special role in sustaining the research of Eugene Lance, Elizabeth Simpson and other more junior colleagues. Elizabeth and Eugene in turn did much to make that possible as also did Ruth Hunt.
For three decades the core of Medawar's scientific work was devoted to identifying the homograft reaction, turning it into a powerful tool of immunological investigation, and finding ways to circumvent it. His early period of research on growth, rich in promise, led afterwards to increasing interest in cancer and return to embryology; but his intellectual development cannot be divided into neat compartments, for time and again he returned to his earlier interests.
ON GROWTH AND DEVELOPMENT
Magdalen gave Medawar, as a fresh graduate, accommodation and financial sec urity, and complete freedom to choose his own topics of research. This he exercised initially by moving down South Parks Road to the Sir William Dunn School of Pathology, where Florey had gathered a formidable team with wide interests, although the triumph of penicillin was still a few years away. The practical approach charac teristic of that School must have provided a stimulating counterpoint to the intellectual challenge of High Table at Magdalen. Medawar began to study a factor previously identified by Heaton in extracts of malt, which could inhibit the growth of explanted chick fibroblasts. This took him directly into tissue culture, then the most sophisticated procedure available for studying cell growth, and the kind of thing that in Oxford only Florey's laboratory could provide. The factor is not a protein and was identified by Medawar as a carbohydrate with aldehyde as the active group; it has never been fully characterized and may well comprise a mixture of substances. Medawar seems to have enjoyed grappling with the guarded terminology then used to describe such compounds. Conversations with Robert Robinson, the great organic chemist, no doubt helped.
Having repeated the extraction procedure, Medawar showed that the inhibition of outgrowth from embryo heart fragments provides a quantitative assay for the factor. He went on to broaden the range of mesenchymal cells that it would inhibit and to show that it left epithelial cells unaffected. As the list of target cells grew, he became more hopeful that the factor might mimic the action of some naturally occurring agent of growth control. The problem was to show that it was a specific inhibitor and not merely something lethal. Although he found various circumstantial arguments in favour of this interesting possibility, the case remained unproven. When modern research on growth factors arrived 40 years later it continued to depend on the use of cells grown in culture; but it requires methods of handling minute amounts of protein not available in the 1930s.
The paper that Medawar published on this work (1) already has many of the features that became his hall-mark: powerful ideas, able to place a simple fact in the widest possible context; a highly distinctive style, able to manipulate with total confidence a vocabulary far wider than that usually employed within science; and the authority (here of a 22-year-old) to assign previous work to its place within a novel conceptual framework.
A glance at the papers that appear before and after M edawar's in that 1937 journal is revealing. Then, as now, the conventional paper starts with an introduction that cites the work of others and goes on to describe methods. Medawar has none of that: a description of his conceptual framework comes first, and only when we reach 'Previous Work' do the citations begin.
The next paper appears three years later in the Proceedings o f the Royal Society (2), as do many of his best papers, and like the first has an unconventional format with six pages of close argument about the nature of growth equations before we reach 'Technical M ethods'. The same system is used here, to measure the 'growth energy' of the chicken's heart by determining the resistance of outgrowing cells to inhibition by H eaton's factor. This resistance he found to decline exponentially with age, as did the growth rate of the heart within the embryo.
Much of this paper concerns the nature of growth equations and his discussion should be read alongside others devoted to the same subject that he published over the next few years (4, 6, 8, 9) . He developed a deep interest in what he termed 'the laws of growth and in the equations through which they can be expressed. This was a subject that had much exercised biologists over the previous 30 years and Medawar particularly acknowledges his debt to Charles Minot, whose classic on The problems o f age, growth, and death appeared in 1908, to Bertalanffy and Lotka, and to James Gray and Julian Huxley. Medawar's contribution was one of critically assimilating an extensive literature, clarifying its mathematics, and summarizing it on various occasions in a form which is readily accessible to biologists (5), or treated at greater depth (11).
As the tides of war rose and Medawar's experimental work begun to develop in the new directions described below, he continued to think about problems of growth. He read the papers of D 'Arcy Thompson and applied his analysis of relative growth to data in the literature of human growth (8). It would be a mistake to dismiss this work as mere theorizing, an activity that Medawar held in suspicion. H e enjoyed quoting, from the world of chess, Bogoljubov's ironic designation as the 'great theoretician'. W hat M edawar was searching for were very simple rules, such as 'what results from growth is itself capable of growing', and that the specific growth rate declines more and more slowly with increase in age. It is the baby, he liked to quote from Minot, who hurries fastest to the grave. The cause of relative growth should be sought in a gradient of concentration of what would now be termed a 'morphogen'. H e avoided premature speculations about mechanism, but I have little doubt that he would have pursued experimentation in that direction had his interest not been deflected. Perhaps his experience with H eaton's factor had taught him how difficult it would be to make progress with morphogens using the techniques of biochemistry then available. M ed awar himself did not think that this early work 'amounted to much'. Its main interest now lies in watching a powerful young mind confronting the ideas and limitations of pre-war biology.
The early interest in growth left him with a lasting interest in demography, the science of population growth that he returned to in his 1957 Reith Lectures, and in ageing (29). W hen progress made in organ transplantation opened up an experimental approach to ageing, he helped found a chair in that subject for his friend Peter Krohn in Birmingham.
T h e h o m o g r a f t r e a c t i o n
During the Battle of Britain the Medawars heard an aeroplane flying low over their Oxford garden and then an almighty crash. It was not a bomb but one of our own planes and the pilot survived in a badly burned condition. The doctors phoned to ask if there was any way that his experience in tissue culture could help the young man. There was not, but M edawar's attention now was immediately concentrated on the treatm ent of burns.
The Glasgow surgeon Thomas Gibson had been examining the fate of grafted skin in man and like others he had come to acknowledge that foreign skin could not be used to make a permanent graft. Under the auspices of the War Wounds Committee of the MRC, he and Medawar now carried out a joint experiment on the mechanism of rejection. Medawar travelled up to Glasgow, where he later claimed that the diet consisted of allotropes of porridge. There he first became acquainted with his favourite subject of experiment, the skin graft.
The Glasgow experiments were simple but decisive. A young epileptic woman had sustained extensive burns. Gibson transplanted onto the raw area of her back a set of Thiersch 'pinch' grafts taken from herself (autografts) and from another individual (homografts, or in modern usage 'allografts'). In addition, and this was crucial, a second set of grafts was later transplanted from the same donor. At intervals some of the grafts were removed and examined in histological sections. This was the first systematic study of the process of rejection, and it was accomplished with all of Medawar's charac teristic verve. There was no consultant histopathologist, for instance; Medawar's glee in mastering that vocabulary is evident in their paper (7) and must have been enhanced by realizing that some of that Oxford morphology was being put to good use.
From this study two important conclusions emerged, one negative and one positive. The negative was that no immediate local reaction to the foreign grafts could be detected, such as the previous authority Loeb would have predicted from his theory of 'individual differentials', i.e. auto-and homografts both initially heal in and acquire a blood supply: there is no innate and immediate mechanism for recognizing foreign ness. Nevertheless Loeb's theory does apply to grafts between invertebrates, one may note in passing. It was the positive conclusion that really mattered: the reaction to the homografts began in this experiment to acquire the features of an immunological response. Thus, and this was the key novelty in the experiment, the second set of grafts were rejected far more rapidly than the first. In addition, a latent period characteristic of the immune response intervened before rejection of the first set of grafts com menced, during which the appearance of homografts and autografts could not be distinguished.
It has been claimed that this was the experiment that established that homografts cannot survive. This is an exaggeration, as that fact was already well recognized by practising surgeons; what matters is that the rejection process was now placed on a scientific footing and one could begin to think in terms of immunology rather than the niceties of surgical technique.
From this period stem some of the 'Medawarisms' by which his students recognize one another and which have been passed down to successive generations. 'A monot onic function of age' was already out and about; now 'second-set grafts' entered and the 'exquisite sensitivity' of the homograft reaction was to follow.
Back in Oxford, Medawar continued to study the fate of homografts, in rabbits, chosen as a convenient animal and not 'for any intrinsic merit'. With the War going on, and an urgent need for results, he worked harder than ever. In two lengthy papers he reported to the War Wounds Committee (9, 10) that he had devised a uniformly successful technique of skin grafting to the wall of the thorax, a technique that was to last up to the present. Using it, he confirmed the existence of a latent period before rejection of homografts commenced, and that second set grafts were rejected more rapidly. But now, in his rabbits, he could measure the survival times with precision. Bringing his previous experience with life tables to bear, he introduced the 'median survival time' as the critical end-point, one which has become universally accepted. He described massive invasion of the graft by lymphocytes, thus laying the ground for the later discovery that these lymphocytes are the agents of destruction, although to begin with he thought rather in terms of antibodies mediating local anaphylaxis. The evidence for an immune reaction continued to grow: the state of heightened resistance to second set grafts applied all over the body, indicative of systemic immunity, although a slightly enhanced local immunity could be detected; a dosage phenomenon applied, whereby a small graft is rejected more slowly; above all, the heightened graft rejection proved specific, in the sense that skin from a different donor was usually rejected less rapidly than skin from the original one.
As M edawar immediately realized, this last point is perhaps the most important, for it took him into genetics, the realm that is now termed immunogenetics or histocom patibility genes. By transplanting skin within a panel of rabbits he showed even at this early stage that at least seven independently controlled antigens segregated among his rabbits, but he also realized that these animals were not ideal for this kind of study (although because of their outbred nature they did provide a good model for man, which is what m attered at the time). This is a subject to which he returned in his Croonian Lecture (37). Meanwhile, a young American came to his laboratory in Oxford after the W ar to pursue the genetics of skin-homografts, but left without leaving an account of his work (his name seems to be lost). In the early 1950s Peter Gorer went to Bar H arbor to work there with George Snell, and together they showed that the blood group antigen H-2, which G orer had identified in the mouse during the 1930s, controlled the rejection of tumour transplants. That experiment provided the key that unlocked immunogenetics and the transplantation of skin eventually had little to add. As a student of M edawar's it shook me to discover in 1953 how far George Snell had progressed in manipulating the H-2 genes. Medawar did stimulate Peter Krohn to carry out the first analysis of the genetics of normal tissue histocompatibility antigens. M edawar recognized the intellectual challenge of genetics, and the insight that it gives into biological mechanisms. His analysis of the formal genetics of the homograft reaction was, so far as it went, impeccable. Later he helped bring Walter Bodmer to Oxford from Stanford and delighted in J.B.S. H aldane's company in University College London. But I wonder if his reluctance to pursue the genetics wholeheartedly may reflect some division of territory with E.B. Ford from the Oxford days.
Medawar had one more contribution to make to the problem before leaving Oxford. He showed (12,13) that immunity to skin homografts could be evoked by leucocytes and therefore that the transplantation antigens responsible must be widely distributed in tissues; furthermore the leucocytes could immunize rabbits far more effectively if injected intradermally rather than intravenously, and he noted the implication that graft rejection and skin sensitization must have something in common. This was beginning to suggest that lymphocytes themselves, rather than any antibodies that they might produce, would be responsible for destroying homografts. This we now know to be correct, but at the time the experiments that he did in co-culturing skin with chunks of foreign lymph nodes failed to demonstrate any attack (17).
Thus by the time Medawar left Oxford in 1947 he had discovered once-and-for-all that grafts of tissue between unrelated individuals are rejected by an immune response and that the response was probably not mediated by conventional antibodies. Before moving on it is worth noting the influences that prompted these ideas. In later years Medawar liked to emphasize the extent to which the immunological ideas of the 1940s were dominated by medical bacteriology and certainly immunology was not then regarded as an independent science. It had no journal of its own in Britain and Medawar neither then nor in his Croonian lecture ever cites the Journal o f Immunology (although a paper of his (1958) starts the British journal Immunology). Perhaps its very novelty made immunology particularly attractive. Certainly his students in Oxford were the first science undergraduates to hear about the subject in this country, although today one cannot imagine a biology course that would omit it. Nevertheless immunol ogy as a science had already begun: Landsteiner's great monograph had appeared in 1936, and Woglom's 1935 review had already implicated the immune response in the rejection of tumour transplants; Burnet and Fenner were bringing biological ideas to bear on immunology, and greatly influenced Medawar and his colleagues.
P i g m e n t c e l l s
In 1947 Medawar moved to Birmingham at the urging of Solly Zuckerman and found other supporters in the jungle of medical professors there, notably John Squire. Becoming the head of a university department meant that he could assemble a coherent group of research students. Rupert Billingham came from Oxford, and they were joined by Leslie Brent and later Elizabeth Sparrow. I stayed on in Oxford. The interest of the group began to diversify, and it was on the biology of pigment cells that they made their first and last serious mistake. Perhaps we learn most from mistakes; at any rate I shall tell the story in detail.
Rupert Billingham came back to Oxford from the War and, after looking around for a coherent project, commenced a study of the pigment cells of the guinea pig under Medawar's supervision. Together they worked for some seven years on this subject and co-authored a series of publications (18, 19, 25) . To begin with they knew only that black pigmentation tends to spread: this is evident simply from the appearance of black-on-white spots. On a family walk in 1948 Medawar pointed out to me with delight a herd of spotted pigs, each with its black spots surrounded by a ring of black skin still with white hair, where the pigment had not yet spread down into the hair follicles. He had noticed that when the black skin of a guinea pig is autografted into a white spot, the black pigment spreads outward beyond the edge of the graft. Their first discovery was that white spots have what they took to be 'white' or pigmentless pigment-cells. Medawar had earlier found that upon incubation with commercial trypsin, a piece of skin could be split apart to yield a clean upper layer of epidermis (3). Billingham and he then demonstrated that a gold-impregnation technique would light up the branched cells which they took to be pigmentless pigment-cells (15). These are the cells that Langerhans had first observed in 1868, that still bear his name, and that he had mistakenly identified as nerve cells. In thinking that these cells might be pigmentless pigment-cells Billingham and Medawar had powerful support, for the eminent French histologist Masson had independently, and at about the same time, reached the same conclusion. A fact which seemed to support this conclusion is that albino animals do indeed have pigmentless pigment cells. At any rate, from this false premise, they went on to develop a theory of infective transformation of pigmentless pigment-cells by their pigmented neighbours.
As we now know, mainly from staining with antibodies, Langerhans cells are quite unrelated to pigment cells and belong to a group of dendritic cells that are derived from precursors in bone marrow rather than from neural crest. This group includes the veiled cells of lymph and the interdigitating dendritic cells of lymph nodes; they express M HC Class II molecules, function as presenters of antigen to T-cells, and pertain to the immune system. True albinos are white because they do have pigment cells which have an enzyme lesion that prevents them from making pigment, whereas white spots are white because pigment cells do not enter that part of the skin (or enter but do not survive); the exception that proves the rule, as William Silvers later discovered, are black-eyed white mice which have no pigment cells in skin, and have in effect one giant spot covering their entire skin. None of that was known in 1950.
From this misleading start Billingham and M edawar went on to develop their theory of pigment spread in a series of substantially documented and closely argued papers (18, 19, 25) . They set forth four hypotheses: invasive replacement, diffusion of a pigment-inducing factor, pigment-cell migration, and 'infective cellular transforma tion'. The first two were relatively easy to dispose of, by means of two experiments that drew on their growing confidence in the skin graft as an experimental tool. An autograft of white sole-of-foot or nail would blacken when placed next to black body skin, while otherwise retaining its original character: that eliminated invasive replace ment. The newly blackened area around a black-on-white graft could be transplanted and so used to start a new source of blackening, through four successive cycles, thus disposing of a diffusible but non-heritable factor. Pigment-cell migration was more difficult to deal with, not surprisingly because, as we now know, that was almost certainly the correct explanation, and as they already knew that the precursors of pigment cells would have had to be good migrators in order to move from neural crest to their final destination in skin. But argue against migration they did, in the following way: (i) tissues such as tongue or brain have no resident pigment-cells of their own, and grafts of skin to those sites do not seed out pigment-cells; (ii) the space to be occupied by pigment cells migrating into white skin is already occupied by the supposed pigmentless pigment-cells; the supposed pigmentless pigment-cells have the same location (e.g. at the bases of epidermal ridges) as the sites which end up containing black pigment cells; (iii) pigment-cells are known to secrete melanin granules into neighbouring epidermal cells, and could therefore be expected to secrete the hypo thetical pigment-forming system into neighbouring pigmentless pigment-cells; (iv) when a red autograft placed on black skin itself blackens, nowhere are black and red pigment-cells mixed, but they remain rather in discrete areas; (v) the seeding experi ment. In that experiment a suspension of cells from the pigmented skin of a donor is deposited onto a pigmentless bed shallowly cut in a foreign-host so that the bases of the hair follicles remain intact and available for seeding into; eventually the skin heals, and in a proportion of cases the pigment remains and spreads. The longer, and therefore larger, the pigment of foreign origin becomes, the more likely it is to go on surviving (in contrast the larger the dose of a full skin homograft, the more briskly is it rejected); the pigment of foreign origin remains antigenic, and can at any time be bleached by a conventional skin homograft from the original donor.
What a cogent set of arguments it seemed at the time and how salutary is the message from this episode. Within M edawar's group the migration of pigment became superceded as an interest by immunological tolerance, but when Billingham migrated to the U.S.A. in the mid-1950s he revived his old work. Within a few years Silvers and he established that pigment spread only as a result of pigment-cell migration, and for their proof they needed no more than the old transplantation methods. O f course data were not mishandled in the original work and indeed some of the original experiments turned out to have valuable consequences: the transplantation of sole-of-foot, nail, and tongue laid the foundations of later work on the control of gene-expression in epithelia, whereas the seeding experiment anticipates later work on immunologically privileged sites. What the whole episode illustrates so vividly is the grip that exciting ideas can exert on the interpretation of data.
Those ideas are worth a glance, if only because of the clarity with which they are expressed in M edawar's review (14). They are encapsulated in the term 'plasmagenes', coined to denote heritable elements that could under certain circumstances spread from cell to cell, and that were believed largely to account for the differences between cells that could be maintained in tissue culture or upon serial transplantation. The concept survived through the 1940s into the 1950s, only to die out by around 1955 when confronted with the central dogma of molecular biology and the rigorous limits set by the observed location of DNA within cells. To judge from M edawar's citations, and from what he taught me in tutorials in 1945-46, the ideas which most influenced him were those of Darlington on viruses and of Sonneborn on non-Mendelian inheritance in P a r a m e c i u m . These stimulating, original, and sometimes highly uncriti cal ideas seemed able to translate microbial genetics, as fathered by Lwov and Monod in France, and in Britain by Pontecorvo, into concepts applicable to the tissue cells that Medawar loved. Tracy Sonneborn told me that he finally gave up hope that his Paramecium experiments would provide a valid model of tissue differentiation when DNA was found in kappa particles.
Im m u n o l o g i c a l t o l e r a n c e
This, the most glorious chapter, opened when the Edinburgh geneticist H.P. Donald asked Medawar if he knew of any way to distinguish between monozygotic and dizygotic twin cattle. This seemed a straightforward problem for homografting to solve, as skin grafts had already been used elsewhere to sort out problems of disputed parentage in humans. Billingham, Brent and Medawar (this is the order in all their publications; Medawar usually followed the uninformative but generous practice of listing authors alphabetically) accordingly set out to exchange skin grafts between the cattle twins that the Animal Breeding Research Organisation provided. To their surprise, most of the grafts between twins that were definitely dizygotic were accepted (23). Their attention was then directed by the Burnet and Fenner monograph (men tioned above) to the work that Ray Owen had been carrying out in Wisconsin over the previous five years. Owen and his colleagues had discovered that in the blood of dizygotic twin cattle there are often mixed populations of red blood cells, which could be detected by blood grouping; they believed that they resulted from an exchange of blood-forming cells via the synchorial placenta which occurs in cattle. Owen even had a student who reproduced the condition by injecting marrow into embryonic rats, but his thesis work was never published (cited in 30). Owen had concluded that the foreign blood-forming cells must have escaped elimination by the immune response of the host. M edawar's group coined the term 'chimaera' to describe an individual made up of cells derived from two or more zygote lineages and it has entered general use. They went on to show that in dizygotic twins of mixed sex the females that accepted their brothers' skin were nearly always freemartins, i.e. sterile with some degree of masculinization, presumably from exposure to their brother's hormones or hormone-pro ducing tissue (24). The stage was now set for an experimental study in a laboratory animal.
By this time M edawar together with Rupert Billingham and Leslie Brent had moved to London, where he occupied the Jodrell Chair of Zoology in University College London. Their first publication (26) describes a litter of CBA mice that had been injected as foetuses with cells from the A strain of white mice; when nearly adult they were grafted with A skin, and three of the animals retained their homografts for 10 weeks. At this stage two of them received lymph node fragments from a normal CBA mouse that had rejected skin grafts (primed lymphocytes) and they promptly pro ceeded to reject their hitherto tolerated grafts. This experiment, together with others on mice and chickens, established that tolerance can be acquired by pre-emptive exposure to foreign cells, that this condition is specific to the antigens of the donor, and that it must reside in the immune system itself rather than result from antigenic modulation of the graft or blockade of access to the graft. They fully realized how strongly these first results supported Burnet and Fenner's idea of adaptation of recognition-of-self in the developing immune system, and subsequently that idea has never seriously been challenged.
In order to make possible a full investigation of their newly discovered phenomenon of tolerance, it was necessary first to gain a better picture of the homograft reaction in mice. Neither guinea pigs nor rabbits would do, as their young are born at a stage that is immunologically too mature, and in any case the progress made by Snell with their genetics had made it plain that the future lay with mice. So in the first of a series of papers that bore the common heading 'Quantitative studies on tissue transplanta tion' the group established a highly reproducible method of skin grafting mice, it showed that mice could be permanently immunized by a single homograft as judged by accelerated graft rejection, and showed also that this immunity could be transferred by lymph node cells but not by serum (28). Because the transferred cells evidently function perfected well in a syngeneic host, they termed the outcome of this transfer 'adoptive' immunity, another term that has entered general use.
The A and CBA mice that they used in these experiments, it is interesting to note, descended from mice that had originally been bred in Bar H arbor by C.C. Little and his colleagues; Medawar's colleague in University College London, j.B.S. Haldane, had imported them 20 years earlier to study the transplantation 'factors' that he had guessed might turn out to be antigens. Haldane persuaded P.A: Gorer to take up the study, and Medawar and Gorer thus used the same stock. The rating on the pet deck of the SS Mauretania who looked after the mice that I imported in 1954 told me that H aldane's were his last cargo of mice. Gorer raised the first antibodies to the Major Histocompatibility Complex and was at first most reluctant to believe that they were not the agents of homograft-destruction.
The third paper was the crowning glory of the series, published as a 60 page monograph complete with 20 photographs of miscellaneous mice, chickens and a duck (30): it must have impressed the gentlemen in Stockholm and it is still great fun to read. Previous work, including that of their closest competitors Owen and Milan Hasek (in Prague) is summarized; mice, rats, rabbits and birds pop out all over the place and are all made tolerant; the timing of susceptibility is established; so is specificity, and cells of different types are shown to generate cross-tolerance; partial tolerance is identified by adoptive immunization, the tolerant state is shown to be central and not peripheral; parabiosis of chicken egg gives rise to chimerism of red-blood-cell-forming tissue, as in the twin cattle, and to full tolerance. The implications of these findings are brought out in many directions, but the central idea is that the way tolerance is acquired in these experiments tells us how natural tolerance-of-self must itself be acquired: namely by exposure of the immune system to self-molecules during devel opment.
The mechanism by which tolerance-of-self is acquired is now known to be the elimination of self-reactive lymphocyte clones. Medawar probably first heard of that idea at the 1960 Ciba Symposium at which both he and Burnet spoke (41). On that occasion Medawar explained that he was still attached to another idea, which was presented also in the original 1956 paper, that tolerance might represent 'a heritable cellular transformation, akin to ... that which allows bacterial clones ... to resist the activity of antibiotic drugs' (in the 1956 paper that idea was attributed to Burnet and Fenner). Burnet on the same occasion advocated his new, and much simpler, idea of clonal elimination. Neither in 1956 nor in 1960 did Medawar devote much attention to speculation about mechanism. Burnet may have got it right first, but then he had less hard data to discuss.
The concept of acquired immunological tolerance greatly influenced the develop ment of ideas about two major medical problems: the transplantation of organs and tissues, and auto-immune disease. Roy Caine tells us that when asked about the relevance of acquired tolerance to clinical transplantation, Medawar replied 'none at all'. No doubt he did not wish to raise false hopes and was too modest to mention the group's published ideas on that subject (38), but in a sense he was quite right! It is immunosuppressive drugs that have become the main tool of the clinician in both these areas, rather than any antigen-specific manipulation of the immune system. Neverthe less Medawar's work performed the immensely important service of making transplan tation scientifically respectable and gave the clinicians a well-defined goal to attain. Moreover, antigen-specific suppression of the immune response by something akin to acquired tolerance remains an aim of research in transplantation and auto-immunity. P r i v i l e g e , e n d o c r i n o l o g y , a n d e n h a n c e m e n t Acquired immunological tolerance can be viewed as the ultimate escape from the tyranny of the homograft reaction, but three other possibilities also attracted Medawar's attention. None of them seemed quite so blunderbuss as the immunosuppressive drugs currently in use, and all of them had the added attraction of providing fresh insight into the working of the immune system.
One of these was the immunologically privileged site. As Billingham and Medawar first showed by animal experiment (16), anatomical sites that lymphocytes do not visit, notably the brain and the anterior chamber of the eye, provide a haven where homografts may survive indefinitely. The survival of foreign pigment cells in the skin, as we now realize, illustrates the same point. In later studies with the visiting American surgeon Paul Russell (33), homografts of adrenal tissue were shown to survive in the anterior chamber, where their fate could be followed with precision, and where they could be destroyed by adoptive immunization ('immunological adrenalectomy'). They also found, contrary to their hopes, that endocrine tissue per se enjoyed no special immunological privilege. Thus for endocrine tissue, and indeed for any other tissue that can function ectopically, transplantation into an immunologically privileged site offers a rational solution to the rejection problem. For obvious reasons transplant surgeons have hesitated to use either the eye or the brain in this way, but recent research on Parkinson's disease has revived interest in the transplantation of homo grafts into the brain.
Steroids began to enter clinical use just after the War, and one of the first effects noticed was in depleting lymphocytes and inhibiting inflammation and the immune response. M edawar and Billingham found in Peter Krohn an endocrinologist willing to join them in examining the impact of hydrocortisone on the homograft reaction (20, 21) . Jointly with Elizabeth Sparrow the study continued (32) and a small but significant prolongation of the survival of skin homografts was obtained. Steroids are now widely used to suppress the reaction to kidney grafts and it has become clear that the reaction against an organ graft is considerably easier to suppress than that against skin. These pioneering studies on immunosuppression and immune-avoidance led Medawar to enquire why the mammalian foetus does not succumb to the homograft reaction. His conclusion (27) that neither immunological privilege nor endocrine factors can ade quately explain viviparity remains true today (for a recent review of Medawar's contribution to this topic, see Billington, Immunology Letters, 1989) .
After their discovery that much of the homograft reaction takes place in the lymph node draining a graft (28) it occurred to the group that antibodies might be used to prevent antigens getting from the graft to the node, a mechanism that they termed 'afferent inhibition' (31). This possibility they began to explore, starting from the well-recognized phenomenon of 'enhancement', in which pre-treatment of a mouse with lyophylized donor tissue favours the survival of a subsequent homograft of tumour tissue. With their skin grafts, alas, the effect turned out to be detectable but so slight as to offer little hope of practical use (43). Later experimental work suggests once again that an organ graft, such as kidney, is more amenable to this manoeuvre, but enhancement has not entered clinical use.
T h e n o r m a l l y m p h o c y t e t r a n s f e r r e a c t i o n
As an alternative to the manoeuvres mentioned above, the homograft reaction could potentially be avoided by picking compatible donors and hosts. For this purpose, very accurate typing would be required.
Foreign lymphocytes generate a homograft reaction in the skin of the guinea pig that has all the features of a delayed hypersensitivity reaction (40, 44, 46, 47) . Leslie Brent and Jean Brown managed to dissect the reaction into its constituent parts of graft-versus-host and host-versus-graft responses. But as it turned out, the logistics of transplantation combined with advances in serology prevent this test entering clinical practice for typing transplant donors. They also tried out the 'transfer factor' of their friend and occasional colleague Jerry Lawrence, of New York University, but the effect on skin hypersensitivity claimed for it in humans proved not to be reproducible in the guinea pig.
T r a n s p l a n t a t io n a n t i g e n s
A modern presentation of the homograft problem would start from the molecular biology of transplantation antigens and certainly for any forward look towards new forms of treatm ent this would be an important consideration. Medawar foresaw that need and invited the biochemist Marion Ruszkiewicz to join the group at UCL Although they did manage to extract transplantation antigens out of cells, their efforts made little further progress, largely because of limitations in the biochemical tech niques then available (35, 36, 39, 42, 65) .
Im m u n o s u p p r e s s i o n
By the time Medawar moved to the National Institute for Medical Research in 1962 it had become clear that in the short run, at least, neither acquired tolerance, typing, nor antigen-specific interruption as outlined above would be likely to solve the transplantation problem. Using the immunosuppressive drug 6-mercaptopurine, Roy Caine had already succeeded in transplanting kidneys and other surgeons with other drugs were soon to follow in his footsteps. Medawar set out to find something better, that would focus more closely on the lymphocytes responsible for graft rejection.
His friend Michael Woodruff, with whom he had worked previously on a visit to New Zealand (34), had begun to examine anti-lymphocyte serum (ALS) as an immu nosuppressive agent. So the group proceeded to test this reagent on the normal lymphocyte transfer reaction, as mentioned above. The results were impressive: ALS inhibited the reaction, something that the current immunosuppressive drugs could not accomplish. A procession of young American doctors and surgeons joined the National Institute, Robert Tamb, Ray Levey and Eugene Lance, as did Simmie Jooste from South Africa and David Hamilton, and together with Medawar they examined the effects of ALS more widely (48-55). They obtained greatly prolonged homograft survival, successful xenografts, and (in combination with cell transfers) tolerance induction in adult mice. The special value of ALS seems to lie in its ability to attack lymphocytes selectively, acting particularly on the recirculating population of T-cells. A pioneering clinical trial was carried out on the effect of ALS in multiple sclerosis (57). The results were not entirely negative, but (as with other treatments) the results obtained with this chronic but variable course disease did not warrant further trials.
ALS has to this day a niche in clinical medicine; but it has never come to occupy quite the position that M edawar expected, partly because of its expense and partly because increasingly effective immunosuppressive chemicals have been discovered. Nevertheless, the monoclonal antibodies that stem from ALS currently offer one of the more hopeful prospects in immunosuppression.
T u m o u r i m m u n i t y a n d im m u n o p o t e n t l a t i o n
In the final phase of his scientific life when physical incapacity would have defeated a lesser man, M edawar developed a new interest in tumour immunity and its poten tiation. Cancer cells share many features in common with foetal cells and he liked to claim that the theory of 'anaplasia' would have convinced all tumour biologists, did they not believe her to be a 'defunct princess of the Russian imperial family'! With the aim of detecting onco-foetal antigens, he had mice 'immunized' with foetal cells, in conjunction with induction of tumours by methylcholanthrene. Immunization prior to application of the carcinogen inhibited tumour production, while doing so afterwards enhanced it (56,58). This result delighted him, as in his eyes it confirmed the discovery by McMahon at Harvard that early pregnancy gave a measure of protection against mammary cancer. They tried to characterise the antigens in question, but like others confronted with this problem, could make little progress with these epitopes that are recognized only by T-cells.
Immunopotentiation attracted his attention as a result of a dietary effect noted in the mouse colony at the Clinical Research Centre, where Medawar was then working (59). This led to studies that identified vitamin A acetate and interleukin-2 as powerful stimulants of the immune response to tumours and to transplants (60-62, 64-67, 68) . The last research paper he wrote as lead author at the age of 66 may have a more orthodox format than that of his first written at the age of 22, but it has all the same clarity and vigor. 
